Research Article

Differential Gene Expression Profile of Renin-Angiotensin System in the Left Atrium in Mitral Regurgitation Patients

Table 3

Comparison of mRNA levels through quantitative PCR in the left atria among MR patients with heart failure, aortic valve disease patients with heart failure, and normal controls.

Gene nameMR ()AVD ()NC () value
MR vs. NCAVD vs. NCMR vs. AVD

ACE12.22 ± 0.4812.37 ± 0.319.85 ± 0.660.0230.0050.657
ACE211.61 ± 0.6912.83 ± 0.347.57 ± 0.320.0030.0020.149
AT113.27 ± 0.3614.05 ± 0.4712.04 ± 0.290.0130.0100.126
ENPEP8.86 ± 0.249.52 ± 0.318.14 ± 0.100.0070.0020.068
AGT5.18 ± 0.284.91 ± 0.254.09 ± 0.220.0070.0530.594
CTSA6.24 ± 0.255.13 ± 0.194.44 ± 0.310.0030.0710.006
THOP19.47 ± 0.428.83 ± 0.247.89 ± 0.080.0020.0070.424
NLN10.60 ± 0.2910.00 ± 0.188.72 ± 0.300.0050.0200.214
ANPEP10.52 ± 0.5510.66 ± 0.737.03 ± 0.520.0010.0050.923
CTSG11.71 ± 0.4811.73 ± 0.479.94 ± 0.590.0420.0420.949
LNPEP7.91 ± 0.556.17 ± 0.275.18 ± 0.400.0050.0390.013
MME11.08 ± 0.5410.66 ± 0.237.88 ± 0.660.0100.0020.441
CMA113.88 ± 0.4613.43 ± 0.3811.50 ± 0.940.0630.0530.298
CPA311.30 ± 0.7710.59 ± 0.417.64 ± 0.710.0070.0140.441
MAS16.35 ± 0.9012.19 ± 1.4416.39 ± 0.690.0010.0280.016
NR3C24.89 ± 0.146.08 ± 0.310.007
CYP11B24.56 ± 0.28Unmeasurable

Data are presented as mean ± SEM; quantitative RT-PCR values are presented in △Cq units; MR: mitral regurgitation; AVD: aortic valve disease; NC: purchased samples from normal subjects. ACE: angiotensin-converting enzyme; ACE2: angiotensin I converting enzyme (peptidyl-dipeptidase A) 2; AT1: angiotensin II receptor, type 1; ENPEP: glutamyl aminopeptidase; AGT: angiotensinogen; CTSA: cathepsin A; THOP1: thimet oligopeptidase 1; NLN: neurolysin, mitochondrial-like; ANPEP: alanyl (membrane) aminopeptidase; CTSG: cathepsin G; LNPEP: leucyl/cystinyl aminopeptidase; MME: neprilysin; CMA1: mast cell protease 2-like; CPA3: carboxypeptidase A3; MAS1: MAS1 oncogene; NR3C2: mineralocorticoid receptor; CYP11B2: aldosterone synthase gene.